Prediabetes Needs Proactive Management In India: Why? Dr Manoj Khandelwal18 April 2024 11:00 AM IST Prediabetes, also termed intermediate hyperglycemia or non-diabetic hyperglycemia, a high-risk state for developing diabetes, is defined by...
Allergic Rhinitis: Challenges, Treatment Choices and Clinical Spotlight on Fexofenadine Dr. Kamal Kant Kohli1 April 2024 10:30 AM ISTAllergic rhinitis (AR) is a common inflammatory disease affecting the nasal mucosa, induced by inhaled allergens. It is clinically manifested by...
Cefuroxime in Lower Respiratory Infections: Clinical Review Dr. Kamal Kant Kohli22 March 2024 11:19 AM ISTUnmasking the Global Challenge of Lower Respiratory Tract Infections:Lower respiratory tract infections (LRTIs) are a major public health concern,...
Allergic Rhinitis Aggravated by Air Pollutants: Review of International Expert Consensus and Clinical Essay on Fexofenadine Dr. Kamal Kant Kohli16 March 2024 12:43 PM ISTAllergic rhinitis (AR) has become a progressively prevalent inflammatory condition affecting the nasal mucosa, often stemming from exposure to inhaled...
EVERGREEN Webinar: Clinical FAQs on T2DM Care, Addressed by Dr V Mohan Dr Jeegar Dattani6 March 2024 12:29 PM ISTThe Evergreen webinar addressed the clinical applicability of Linagliptin and Dapagliflozin in real-world clinical scenarios of type 2 diabetes....
Allergic Rhinitis in Children: Review of Indian Guidelines and Applicability of Fexofenadine Dr. Kamal Kant Kohli28 Feb 2024 11:00 AM ISTAllergic rhinitis is a common disease that frequently occurs in children and adolescents. The disease has a significant burden that impacts sleep,...
Bedtime Ranitidine for Nighttime Acid Reflux: Choose your Option Wisely! Dr. Kamal Kant Kohli15 Feb 2024 11:45 AM ISTNighttime acid reflux commonly referred to as nocturnal acid breakthrough (NAB) is defined as a persistent decrease in intragastric pH below 4 for...
Top 10 Messages from Evergreen Webinar on Clinical Applicability of Linagliptin Dapagliflozin in Type 2 Diabetes, Addressed by Dr V Mohan Dr Jeegar Dattani12 Feb 2024 12:15 PM ISTDr. V. Mohan, M.D., FRCP (London, Edinburgh, Glasgow & Ireland), Ph.D., D.Sc. D.Sc (Hon. Causa), FNASc, FASc, FNA, FACE, FACP, FTWAS, MACP, FRSE....
Indian Guidelines Review on Allergic Rhinitis and Scope for Use of Fexofenadine and Montelukast Combination Dr. Kamal Kant Kohli22 Jan 2024 11:00 AM ISTAllergic Rhinitis and Its Burden in India: Allergic rhinitis (AR) is a common inflammatory condition that affects the nasal mucosa and is...
Considering Ranitidine in Episodic Heartburn Relief-A Practice Perspective Dr. Kamal Kant Kohli18 Jan 2024 11:14 AM ISTHeartburn is a cardinal symptom of gastroesophageal reflux disease (GERD). (1) It is defined as a sensation of burning discomfort in the chest, upper...
Acute Upper Respiratory Tract Infections: Clinical Review and Therapeutic Scope for Using Clarithromycin Dr. Kamal Kant Kohli12 Jan 2024 12:22 PM ISTUpper respiratory tract infections (URTIs) are among the most commonly encountered diseases in primary care settings, accounting for 17.2 billion...
2023 In Review: Major Developments In The Field Of Endocrinology Dr Akhil Krishna26 Dec 2023 11:15 AM IST Let us take a glimpse into the notable progress and accomplishments within the field of endocrinology for the year 2023. This overview showcases...
